Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling ...

The API and drug product facility is the first of four new manufacturing plants set to be built by Eli Lilly in the US over ...

The Generation Park site will create over 600 permanent jobs, support advanced small molecule production, and play a role in ...

The convergence of biopharmaceutical innovation, contract manufacturing partnerships, and advanced synthesis technologies is redefining how drugs are developed, manufactured, and delivered worldwide N ...

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, ...

AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois. This ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...